Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Complete Title: Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Trial Phase: II/III
Investigator: Doug Hawkins

This partially randomized phase II/III trial studies how well cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or liver cancer after surgery. Drugs used in chemotherapy, such as cisplatin, doxorubicin, fluorouracil, vincristine sulfate, carboplatin, etoposide, irinotecan, sorafenib, gemcitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving combination chemotherapy after surgery may kill more tumor cells.

Keywords:
  • Digestive System Neoplasms
  • Adenocarcinoma
  • Carcinoma
  • Carcinoma, Hepatocellular
  • Digestive System Diseases
  • Liver Diseases
  • Hepatoblastoma
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

Adult
Pediatric
II/III
Doug Hawkins
AHEP1531
NCT03533582
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Digestive System Neoplasms
Adenocarcinoma
Carcinoma
Carcinoma, Hepatocellular
Digestive System Diseases
Liver Diseases
Hepatoblastoma